Celebration of BOPA member’s recent publications
We are delighted to share that so many of our members have had manuscripts published recently. Here are some that we are aware of but if there are others then please contact the research committee so that we can disseminate these to the membership. Authors who are BOPA members are in bold.
Manuscripts
Time to adjuvant chemotherapy and overall survival in advanced-stage ovarian cancer patients in England: a population-based retrospective cohort study
L Steventon, S Nicum, K Man, D Dodwell, Z Wang, A Patel, ... Chambers P
ESMO Real World Data and Digital Oncology
2025
Integrating International Consensus Guidelines for Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) into everyday practice
G Sandhu, J Adattini, EA Gordon, N O’Neill, C Bagnis, AV Boddy, …Chambers P, Morris E
eClinicalMedicine
2025
A methodology for determining dosing recommendations for anticancer drugs in patients with reduced kidney function
G Sandhu, EA Gordon, J Adattini, N O’Neill, P Chambers, DW Johnson, …
eClinicalMedicine
2025
Scoping review identifying interventions that have been tested to optimise the experience of people from ethnic minority groups receiving systemic anticancer therapy (SACT)
J McLean, P Chambers, L Steventon, S Cruickshank, S Nabhani-Gebara
BMJ Quality & Safety
2025
Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review
GA Alarcón Garavito, K Gilchrist, C Ciurtin, S Khanna, P Chambers, …
Trials 26 (1), 65
Editorials
Shaping the UK’s long term relationship with tirzepatide
Peter Robertson, Nicholas Browne
BMJ 2025;388:r394 doi: https://doi.org/10.1136/bmj.r394
(Peter is a BOPA CPCP Subcommittee member)
